HER2+ breast cancer
HER2+ breast cancer makes up 20% of all breast cancers, but what is it, and how is it treated?
This webinar looks at what a diagnosis of HER2+ breast cancer means for you, how treatment has changed over the last few years and what the different options are.
Members of the panel share their experience with HER2+ breast cancer and the treatment decisions they made with their medical team along the way.
Meet our panel
Auckland City Hospital lead medical oncologist Dr Sheridan Wilson talks about why and when HER2+ breast cancer occurs, how it compares to other breast cancers and what the different treatment options are.
Our ambassador and broadcaster Sarah Gandy shares her perspective of being diagnosed with HER2+ breast cancer in 2018, the treatment she went through, and what decisions she had to make along the way.
Aucklander Elly Bhatia was diagnosed with HER2+ breast cancer in 2022, at age 44. She shares the different decisions she made along the way, including whether or not to have neoadjuvant chemotherapy, what type of surgery to have, and what it is like being on Kadcyla.